Evelo Biosciences Inc
OTC:EVLO
Evelo Biosciences Inc
OTC:EVLO
Price:
0.0001
USD
Market Closed
Market Cap:
$1.9k
Balance Sheet
Balance Sheet Decomposition
Evelo Biosciences Inc
Evelo Biosciences Inc
Balance Sheet Decomposition is not available for
Evelo Biosciences Inc
Evelo Biosciences Inc
Balance Sheet
Evelo Biosciences Inc
Evelo Biosciences Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
16
|
38
|
93
|
78
|
69
|
69
|
48
|
|
| Cash |
1
|
13
|
1
|
2
|
5
|
2
|
1
|
|
| Cash Equivalents |
15
|
25
|
92
|
76
|
64
|
67
|
47
|
|
| Short-Term Investments |
0
|
0
|
55
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
4
|
3
|
2
|
3
|
4
|
|
| Total Current Assets |
16
|
39
|
152
|
81
|
71
|
71
|
52
|
|
| PP&E Net |
3
|
4
|
7
|
8
|
18
|
16
|
12
|
|
| PP&E Gross |
3
|
4
|
7
|
8
|
18
|
16
|
12
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
4
|
6
|
8
|
9
|
|
| Other Long-Term Assets |
0
|
2
|
1
|
2
|
1
|
1
|
1
|
|
| Total Assets |
19
N/A
|
44
+135%
|
160
+265%
|
91
-43%
|
91
0%
|
88
-3%
|
64
-27%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
1
|
2
|
2
|
|
| Accrued Liabilities |
0
|
2
|
5
|
9
|
18
|
15
|
10
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
0
|
3
|
0
|
1
|
1
|
0
|
|
| Total Current Liabilities |
2
|
4
|
9
|
10
|
20
|
17
|
12
|
|
| Long-Term Debt |
10
|
10
|
12
|
20
|
30
|
47
|
44
|
|
| Other Liabilities |
1
|
1
|
1
|
1
|
10
|
15
|
13
|
|
| Total Liabilities |
13
N/A
|
15
+14%
|
23
+55%
|
31
+34%
|
60
+96%
|
79
+32%
|
69
-12%
|
|
| Equity | ||||||||
| Common Stock |
34
|
84
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
28
|
56
|
113
|
199
|
293
|
415
|
529
|
|
| Additional Paid In Capital |
0
|
2
|
250
|
259
|
323
|
423
|
524
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
6
N/A
|
29
+427%
|
137
+372%
|
60
-56%
|
31
-49%
|
9
-71%
|
5
N/A
|
|
| Total Liabilities & Equity |
19
N/A
|
44
+135%
|
160
+265%
|
91
-43%
|
91
0%
|
88
-3%
|
64
-27%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
2
|
3
|
6
|
|
Switch to:
Switch to:
See Also
Discover More
